List view / Grid view

Melanoma & Skin Cancer

 

news

SMC ‘U-turn’ offers lifeline to Scottish skin cancer patients

8 August 2016 | By Bristol-Myers Squibb

The SMC initially refused access to nivolumab for Scottish patients, having taken a different view to the National Institute for Health and Care Excellence (NICE), which approved it to treat patients in England and Wales. However, following a review of additional evidence, the SMC decision has been reversed, bringing access…